Dan J. Zhang
St. Joseph's Healthcare
Hamilton, ON, Canada
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
miR-299a-5p is a mediator of fibrosis in diabetic kidney disease by regulating follistatin and cripto-1.
Journal: Communications biology
Published: May 07, 2025
Salvianolic acid B inhibits thrombosis and directly blocks the thrombin catalytic site.
Journal: Research and practice in thrombosis and haemostasis
Published: April 15, 2024
Both sexes develop DKD in the CD1 uninephrectomized streptozotocin mouse model.
Journal: Scientific reports
Published: December 06, 2022
A therapeutic target for CKD: activin A facilitates TGFβ1 profibrotic signaling.
Journal: Cellular & molecular biology letters
Published: September 02, 2022
miR299a-5p promotes renal fibrosis by suppressing the antifibrotic actions of follistatin.
Journal: Scientific reports
Published: June 11, 2020
Dual function of perivascular fibroblasts in vascular stabilization in zebrafish.
Journal: PLoS genetics
Published: April 21, 2020
Follistatin Protects Against Glomerular Mesangial Cell Apoptosis and Oxidative Stress to Ameliorate Chronic Kidney Disease.
Journal: Antioxidants & redox signaling
Published: June 12, 2019
Efficient skin lesion segmentation using separable-Unet with stochastic weight averaging.
Journal: Computer methods and programs in biomedicine
Published: April 29, 2019
Caveolin-1 regulation of Sp1 controls production of the antifibrotic protein follistatin in kidney mesangial cells.
Journal: Cell communication and signaling : CCS
Published: February 08, 2019
The caveolin-1 regulated protein follistatin protects against diabetic kidney disease.
Journal: Kidney international
Published: October 01, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026